Cargill Wins EU Health Claim for Barley Beta-Glucan and Cholesterol Reduction

January 20, 2012

Derived from whole grain barley, Barliv is low in viscosity and invisible when added to foods and beverages.

Cargill (Minneapolis) has successfully petitioned the European Food Safety Authority (EFSA; Parma, Italy) for an article 14 health claim relating to its Barliv barley beta-glucan and lowering of cholesterol. After applying for the claim with 16 scientific references back in May 2011, EFSA has now acknowledged a cause-and-effect relationship.

The permitted health claim may reads as follows: “Barley beta-glucans have been shown to lower/reduce blood cholesterol.”

To qualify for the claim, a product must contain Barliv or any other barley beta-glucan at an average molecular weight between 100 and 2000 kilo Daltons (kDA). Cargill says that a serving of 3 g of Barliv will warrant the health claim.

Derived from whole grain barley, Barliv offers low viscosity and is invisible when added to foods and beverages, says Cargill.

Barley already has a strong standing when it comes to health claims. FDA already allows a health claim for barley beta-glucan (specifically Barliv) and cholesterol reduction. The U.S. agency also allows the following claim for products with soluble fiber (such as barley): “Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."